The delocalized medical biology examinations are carried out outside the laboratory near the patient by staff outside the laboratory, which saves time in obtaining the results. These examinations are subject to the same regulations as examinations carried out in a medical biology laboratory and are the responsibility of medical biologists who retain responsibility for validating the results obtained.This development of the implantation of analytical devices of medical biology in the care units (outside the laboratory of the hospital) can be justified by several factors: medical emergencies, organizational constraints, the distance from the laboratory....In this work we tried to analyze the state of affairs of delocalized biology and to reveal the problems of delocalized biology of our ibn Rochd hospital center in Casablanca.

The Covid-19 outbreak is a global pandemic officially declared on March 12, 2020, with more than two million deaths. To assess the role of Procalcitonin as a biomarker of the specific inflammatory response and C-Réactive Protein as a stable and early biomarker of acute inflammation in pathogenesis and disease severity, we conducted a prospective descriptive study in the biochemistry laboratory of the Ibn Rochd University Of Casablanca Morocco in Covid-19 positive patients hospitalized in resuscitation. These biomarkers were abnormally increased in most of these patients. All of the patients who died had a positive admission CRP that would support a positive correlation between the increase in CRP and the severity of infection, without any correlation between CRP values in our study population with age or sex. The follow-up of the PRC could reflect its severity and should be used as a key monitoring indicator for Covid-19. PCT values at admission can predict the progression to a severe form of the disease. However, its synthesis is inhibited by interferon (INF) -γ, whose concentration increases during Coronavirus-2 infection.